Hydroxyurea dose optimisation for children with sickle cell anaemia in sub-Saharan Africa (REACH): extended follow-up of a multicentre, open-label, phase 1/2 trial
- Resource Type
- Article
- Source
- In
The Lancet Haematology June 2024 11(6):e425-e435 - Subject
Primary Research Articles - Language
- ISSN
- 2352-3026